Miramar Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,772
Closed -$219K 59
2025
Q4
$219K Hold
2,772
0.05% 54
2025
Q3
$228K Hold
2,772
0.05% 56
2025
Q2
$223K Hold
2,772
0.05% 59
2025
Q1
$223K Hold
2,772
0.05% 53
2024
Q4
$227K Hold
2,772
0.05% 55
2024
Q3
$229K Buy
+2,772
New +$207K 0.05% 55
2024
Q2
Sell
-3,275
Closed -$233K 60
2024
Q1
$233K Hold
3,275
0.06% 55
2023
Q4
$217K Hold
3,275
0.06% 57
2023
Q3
$206K Sell
3,275
-370
-10% -$23K 0.06% 62
2023
Q2
$206K Sell
3,645
-130
-3% -$7.21K 0.05% 69
2023
Q1
$219K Sell
3,775
-4,318
-53% -$291K 0.06% 76
2022
Q4
$586K Sell
8,093
-4,693
-37% -$336K 0.15% 53
2022
Q3
$930K Sell
12,786
-725
-5% -$46.3K 0.26% 43
2022
Q2
$848K Buy
13,511
+665
+5% +$44K 0.24% 47
2022
Q1
$903K Buy
+12,846
New +$869K 0.25% 49

Other funds holding MET

Miramar Capital's MET Position: Q1 2026 in Review

Miramar Capital sold out of MetLife (MET) in Q1 2026, closing a stake of 2,772 shares — an estimated $219K sold.

Miramar Capital first reported a position in MET in Q1 2022 and held it in 15 quarters. The position peaked at $930K in Q3 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Miramar Capital reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Miramar Capital sold 2,772 MetLife shares in Q1 2026, an estimated $219K.
  • Miramar Capital first reported a position in MetLife in Q1 2022 and held it in 15 quarters.
  • Miramar Capital's MetLife position peaked at $930K in Q3 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.